The CHAT gene gives your body instructions to make acetylcholine, a chemical messenger that helps nerves activate muscles and support automatic body functions such as breathing. This gene plays an important role in keeping nerve to muscle signaling steady. If the gene does not work well, some people develop a congenital myasthenic syndrome, which can cause easy tiring, droopy eyelids, weak crying or feeding, and episodes of breathing trouble. Effects vary, and symptoms often begin in infancy or childhood.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for building proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
CHATGene function
What if the gene works
The CHAT gene helps make acetylcholine, a chemical messenger that nerves use to send signals. This supports muscle movement, breathing, and automatic body functions such as heart rate.
Risk
What if the gene does not work
Variants in the CHAT gene most often cause congenital myasthenic syndrome, with muscle weakness and episodes of breathing difficulty or apnea. Effects can range from mild fatigability to earlier, more severe symptoms, depending on how much enzyme activity is reduced.
Treatment
What does that mean for your treatment
Pathogenic variants in the CHAT gene can make acetylcholinesterase inhibitors, especially pyridostigmine, a standard treatment choice because they help improve signaling between nerves and muscles. Some people may also benefit from amifampridine, while treatment response can vary from person to person.
Conditions associated with CHAT
Gene function
What if the gene works
Smooth movement, breathing, and many automatic body functions depend on a chemical messenger called acetylcholine. The CHAT gene gives certain nerve cells the instructions to make the enzyme that produces acetylcholine. This is the core of the CHAT gene’s function: helping signals move from nerve to muscle and between nerve cells in a controlled way.
The CHAT gene helps certain nerve cells make acetylcholine, the messenger used to pass signals onward. Its enzyme combines choline with a small chemical unit called an acetyl group to build that messenger.
By supplying acetylcholine, this gene supports communication where one nerve cell activates the next cell. This is especially important at nerve to muscle connections and in nerves that help control organs and glands.
CHAT activity helps nerve endings keep making acetylcholine when signals need to fire again and again. That steady supply supports actions like breathing, speaking, swallowing, and moving your muscles.
What is a variant?
Within a gene, a genetic variant is a small difference in the DNA sequence. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CHAT gene can change the shape, stability, or amount of the enzyme, so nerve endings make less acetylcholine. The effect of CHAT gene variants on acetylcholine production can range from mild to marked: some changes leave partial activity, while more disruptive variants make the protein unstable or largely inactive. In congenital myasthenic syndrome, variants that reduce function more strongly often lead to earlier symptoms and more pronounced weakness or breathing episodes.
How variants are linked to conditions
Pathogenic variants in the CHAT gene cause congenital myasthenic syndrome with episodic apnea, the main well-established CHAT-related condition. In this CHAT gene variants and congenital myasthenic syndrome link, symptoms often begin in infancy or childhood and can include muscle weakness, poor feeding, droopy eyelids, and episodes of breathing difficulty. Severity varies, and some people have a milder course while others need closer respiratory support.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most do not have a direct impact on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible connection rather than providing a definite diagnosis, especially when more than one gene and environmental factors are involved. Still, in some cases, a single well-characterized variant in a specific gene can be enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For CHAT, the main risk comes from inheritance: a child is affected when they receive a harmful copy from both parents, so family history and both parents being carriers matter most. In people already living with a CHAT-related condition, infections, fever, and physical stress can trigger or worsen weakness or breathing episodes.
Inheritance of CHAT variants
For families asking how variants of the CHAT gene are inherited, the usual pattern is autosomal recessive. This means a child typically inherits one CHAT gene variant from each parent, and the parents are often healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because the CHAT gene is on an autosome, this pattern is the same for boys and girls.
What does my CHAT result mean for my family?
For families with a disease-causing CHAT result, close relatives may also carry the same gene change, even if they do not have symptoms. Brothers and sisters may be affected or may be carriers, and other relatives may also want to learn whether the variant runs in the family. This is most relevant when CHAT is linked to a recognized inherited muscle weakness condition, such as congenital myasthenic syndrome.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CHAT variants uses a blood or saliva sample to read the CHAT gene and look for spelling changes or missing pieces in your DNA. It is often included in a nerve or muscle gene panel, and the result may show a variant that helps explain symptoms, a benign change, or a finding that needs review.
When should I consider getting a genetic test?
Consider testing the CHAT gene if a baby or child has repeated breathing pauses, severe tiredness, droopy eyelids, or muscle weakness that comes and goes, especially during illness or sleep. Testing can also help if this pattern runs in the family or a close relative has a confirmed CHAT-related condition.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies based on the condition involved and the type of variant present. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, transports, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CHAT gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have questions about medicines, side effects, or symptoms that may relate to an underlying health condition, talk with your doctor or pharmacist.
History
Work on the CHAT gene grew out of classic neuroscience studies on acetylcholine in the mid 1900s, when researchers were mapping how nerve cells communicate. Initially understood only through visible traits, later recognized as tied to a specific gene, the enzyme activity now called choline acetyltransferase became a key marker for identifying cholinergic nerve cells in laboratory studies. After the underlying protein was characterized, the CHAT gene itself was cloned and mapped in the late 20th century, which gave researchers a clearer way to study inherited changes. From these first observations, research expanded steadily. In the early 2000s, variants in the CHAT gene were linked to a form of congenital myasthenic syndrome, connecting decades of basic science with patient care.